<p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）内部人士 Mario Schlosser 于 11 月 11 日（星期二）出售了 286,182 股 Oscar Health 股票。股票的平均售价为 15.27 美元，总价值为 4,369,999.14 美元。出售完成后，该内部人士在公司持有 501,148 股，价值为 7,652,529.96 美元。这代表其持股比例减少了 36.35%。该交易已在提交给证券交易委员会的文件中披露，相关文件可在 SEC 网站上查阅。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>Mario Schlosser 最近还进行了以下交易：</p>
<ul>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。股票的平均售价为 18.43 美元，总价值为 7,279,850.00 美元。</li>
</ul>
<h2>Oscar Health 股票下跌 4.2%</h2>
<p>OSCR 的股票在星期四开盘价为 14.09 美元。该公司的 50 日移动平均价格为 18.51 美元，200 日移动平均价格为 16.91 美元。Oscar Health, Inc.的 12 个月低点为 11.20 美元，12 个月高点为 23.80 美元。该公司的流动比率为 0.92，速动比率为 0.92，债务与股本比率为 0.67。该公司的市值为 37.3 亿美元，市盈率为-12.58，贝塔系数为 1.88。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 11 月 6 日（星期四）公布了其财报。公司报告本季度每股收益为（0.53 美元），超出市场共识预期的（0.55 美元）0.02 美元。该季度的收入为 29.3 亿美元，而分析师预期为 30.9 亿美元。Oscar Health 的净利润率为-2.16%，股本回报率为-21.50%。与去年同期相比，Oscar Health 的收入增长了 23.2%。去年同期，该公司每股收益为（0.22 美元）。Oscar Health 已将 2025 财年的指引设定为每股收益。平均而言，卖方分析师预测 Oscar Health, Inc.今年的每股收益为 0.69 美元。</p>
<h2>机构投资者对 Oscar Health 的看法</h2>
<p>一些对冲基金最近买入和卖出了 OSCR 的股票。Vanguard Group Inc.在第三季度将其在 Oscar Health 的持股增加了 2.1%。Vanguard Group Inc.目前持有 20,160,399 股该公司的股票，价值为 381,636,000 美元，在上个季度又购买了 423,184 股。T. Rowe Price Investment Management Inc.在第一季度将其在 Oscar Health 的股份增加了 4.1%。T. Rowe Price Investment Management Inc.目前持有 11,826,245 股该公司的股票，价值为 155,043,000 美元，在上个季度又收购了 467,301 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的股份增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股该公司的股票，价值为 85,258,000 美元，在上个季度又收购了 1,588,395 股。American Century Companies Inc.在第三季度将其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.目前持有 5,298,340 股该公司的股票，价值为 100,298,000 美元，在上个季度又收购了 2,495,691 股。最后，BIT Capital GmbH 在第一季度将其在 Oscar Health 的持股增加了 1.1%。BIT Capital GmbH 目前持有 4,521,445 股该公司的股票，价值为 59,276,000 美元，在上个季度又购买了 47,592 股。机构投资者和对冲基金持有该公司 75.70% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<p>一些研究分析师对该公司进行了评论。Wells Fargo &amp; Company 在 11 月 13 日（星期四）的研究报告中将 Oscar Health 的目标价从 14.00 美元下调至 11.00 美元，并对该股票给予了 “减持” 评级。Zacks Research 在 10 月 13 日（星期一）的报告中将 Oscar Health 的评级从 “强烈卖出” 上调至 “持有”。Piper Sandler 在 8 月 14 日（星期四）的研究报告中将 Oscar Health 的目标价从 14.00 美元下调至 13.00 美元，并对该公司给予了 “中性” 评级。UBS Group 在 11 月 7 日（星期五）的研究报告中将 Oscar Health 的目标价从 11.00 美元上调至 12.00 美元，并对该股票给予了 “卖出” 评级。最后，Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重新发布了对 Oscar Health 的 “卖出（d）” 评级。六位投资分析师对该股票给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat 的数据，Oscar Health 目前的平均评级为 “减持”，平均目标价为 13.14 美元。</p>
<p><strong>查看我们对 Oscar Health 的最新分析</strong></p>
<h2>Oscar Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Oscar Health, Inc.在美国运营健康保险。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转变。它还提供再保险产品。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Oscar Health</li>
<li>在 52 周高点盈利交易股票</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>如何使用 MarketBeat 股息计算器</li>
<li>HIMS 经历了过山车般的旅程。投资者应该上车吗？</li>
<li>经纪评级在股票选择中的重要性</li>
<li>用这三只反弹冠军强势结束年末</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
<p>在考虑 Oscar Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
<p>虽然 Oscar Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

<p>Oscar Health 内部人士 Mario Schlosser 以每股 15.27 美元的价格出售了 286,182 股，总计 437 万美元，减少了 36.35% 的持股比例。该交易在 SEC 文件中披露。Oscar Health 的股票开盘价为 14.09 美元，市值为 37.3 亿美元。公司报告的季度每股收益为（0.53 美元），超出预期。机构投资者持有 75.70% 的股票。分析师的评级不一，目标价格范围在 11 美元到 13 美元之间</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at $7,652,529.96. This represents a 36.35% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at the SEC website.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）内部人士 Mario Schlosser 于 11 月 11 日（星期二）出售了 286,182 股 Oscar Health 股票。股票的平均售价为 15.27 美元，总价值为 4,369,999.14 美元。出售完成后，该内部人士在公司持有 501,148 股，价值为 7,652,529.96 美元。这代表其持股比例减少了 36.35%。该交易已在提交给证券交易委员会的文件中披露，相关文件可在 SEC 网站上查阅。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>Mario Schlosser also recently made the following trade(s):</p>
<div class="lb-trans"><p>Mario Schlosser 最近还进行了以下交易：</p>
</div><ul>
<li>On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。股票的平均售价为 18.43 美元，总价值为 7,279,850.00 美元。</li>
</ul>
</div><h2>Oscar Health Stock Down 4.2%</h2>
<div class="lb-trans"><h2>Oscar Health 股票下跌 4.2%</h2>
</div><p>Shares of OSCR opened at $14.09 on Thursday. The company's 50-day moving average price is $18.51 and its 200 day moving average price is $16.91. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. The firm has a market cap of $3.73 billion, a P/E ratio of -12.58 and a beta of 1.88.</p>
<div class="lb-trans"><p>OSCR 的股票在星期四开盘价为 14.09 美元。该公司的 50 日移动平均价格为 18.51 美元，200 日移动平均价格为 16.91 美元。Oscar Health, Inc.的 12 个月低点为 11.20 美元，12 个月高点为 23.80 美元。该公司的流动比率为 0.92，速动比率为 0.92，债务与股本比率为 0.67。该公司的市值为 37.3 亿美元，市盈率为-12.58，贝塔系数为 1.88。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. Oscar Health's revenue was up 23.2% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.22) earnings per share. Oscar Health has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近于 11 月 6 日（星期四）公布了其财报。公司报告本季度每股收益为（0.53 美元），超出市场共识预期的（0.55 美元）0.02 美元。该季度的收入为 29.3 亿美元，而分析师预期为 30.9 亿美元。Oscar Health 的净利润率为-2.16%，股本回报率为-21.50%。与去年同期相比，Oscar Health 的收入增长了 23.2%。去年同期，该公司每股收益为（0.22 美元）。Oscar Health 已将 2025 财年的指引设定为每股收益。平均而言，卖方分析师预测 Oscar Health, Inc.今年的每股收益为 0.69 美元。</p>
</div><h2>Institutional Investors Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>机构投资者对 Oscar Health 的看法</h2>
</div><p>A number of hedge funds have recently bought and sold shares of OSCR. Vanguard Group Inc. grew its position in shares of Oscar Health by 2.1% during the third quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company's stock worth $381,636,000 after buying an additional 423,184 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC lifted its stake in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. grew its holdings in Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after acquiring an additional 2,495,691 shares in the last quarter. Finally, BIT Capital GmbH increased its position in shares of Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近买入和卖出了 OSCR 的股票。Vanguard Group Inc.在第三季度将其在 Oscar Health 的持股增加了 2.1%。Vanguard Group Inc.目前持有 20,160,399 股该公司的股票，价值为 381,636,000 美元，在上个季度又购买了 423,184 股。T. Rowe Price Investment Management Inc.在第一季度将其在 Oscar Health 的股份增加了 4.1%。T. Rowe Price Investment Management Inc.目前持有 11,826,245 股该公司的股票，价值为 155,043,000 美元，在上个季度又收购了 467,301 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的股份增加了 33.4%。Thrive Capital Management LLC 目前持有 6,343,617 股该公司的股票，价值为 85,258,000 美元，在上个季度又收购了 1,588,395 股。American Century Companies Inc.在第三季度将其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.目前持有 5,298,340 股该公司的股票，价值为 100,298,000 美元，在上个季度又收购了 2,495,691 股。最后，BIT Capital GmbH 在第一季度将其在 Oscar Health 的持股增加了 1.1%。BIT Capital GmbH 目前持有 4,521,445 股该公司的股票，价值为 59,276,000 美元，在上个季度又购买了 47,592 股。机构投资者和对冲基金持有该公司 75.70% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research analysts have commented on the company. Wells Fargo &amp; Company decreased their price target on Oscar Health from $14.00 to $11.00 and set an &#34;underweight&#34; rating on the stock in a research note on Thursday, November 13th. Zacks Research upgraded Oscar Health from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report on Monday, October 13th. Piper Sandler dropped their target price on Oscar Health from $14.00 to $13.00 and set a &#34;neutral&#34; rating for the company in a research report on Thursday, August 14th. UBS Group increased their price target on shares of Oscar Health from $11.00 to $12.00 and gave the stock a &#34;sell&#34; rating in a research report on Friday, November 7th. Finally, Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Oscar Health in a research note on Wednesday, October 8th. Six investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Oscar Health presently has an average rating of &#34;Reduce&#34; and an average target price of $13.14.</p>
<div class="lb-trans"><p>一些研究分析师对该公司进行了评论。Wells Fargo &amp; Company 在 11 月 13 日（星期四）的研究报告中将 Oscar Health 的目标价从 14.00 美元下调至 11.00 美元，并对该股票给予了 “减持” 评级。Zacks Research 在 10 月 13 日（星期一）的报告中将 Oscar Health 的评级从 “强烈卖出” 上调至 “持有”。Piper Sandler 在 8 月 14 日（星期四）的研究报告中将 Oscar Health 的目标价从 14.00 美元下调至 13.00 美元，并对该公司给予了 “中性” 评级。UBS Group 在 11 月 7 日（星期五）的研究报告中将 Oscar Health 的目标价从 11.00 美元上调至 12.00 美元，并对该股票给予了 “卖出” 评级。最后，Weiss Ratings 在 10 月 8 日（星期三）的研究报告中重新发布了对 Oscar Health 的 “卖出（d）” 评级。六位投资分析师对该股票给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat 的数据，Oscar Health 目前的平均评级为 “减持”，平均目标价为 13.14 美元。</p>
</div><p><strong>View Our Latest Analysis on Oscar Health</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Oscar Health 的最新分析</strong></p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美国运营健康保险。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转变。它还提供再保险产品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Profitably Trade Stocks at 52-Week Highs</li>
<li>onsemi Places a $6 Billion Bet on Its Own Stock</li>
<li>How to Use the MarketBeat Dividend Calculator</li>
<li>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</li>
<li>The Significance of Brokerage Rankings in Stock Selection</li>
<li>End the Year Strong With These 3 Comeback Champions</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Oscar Health</li>
<li>在 52 周高点盈利交易股票</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>如何使用 MarketBeat 股息计算器</li>
<li>HIMS 经历了过山车般的旅程。投资者应该上车吗？</li>
<li>经纪评级在股票选择中的重要性</li>
<li>用这三只反弹冠军强势结束年末</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Oscar Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Oscar Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

内部人士抛售：Oscar Health（NYSE:OSCR）的内部人士出售了 286,182 股股票